Barometer Capital Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Barometer Capital Management’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.14M	Buy	38,100 +1,000	+3%	+$33.1K	0.39%	61
2025 Q4	$884K	Buy	37,100 +9,483	+34%	+$306K	0.21%	68
2025 Q3	$957K	Buy	27,617 +10,700	+63%	+$342K	0.22%	65
2025 Q2	$474K	Buy	16,917 +3,400	+25%	+$91.1K	0.13%	90
2025 Q1	$340K	Buy	13,517 +4,100	+44%	+$104K	0.13%	78
2024 Q4	$233K	Sell	9,417 -1,300	-12%	-$36.2K	0.09%	95
2024 Q3	$309K	Buy	10,717 +1,300	+14%	+$35.4K	0.09%	92
2024 Q2	$233K	Buy	9,417 +1,700	+22%	+$48.2K	0.09%	101
2024 Q1	$220K	Buy	7,717 +4,717	+157%	+$175K	0.06%	158
2023 Q4	$122K	Buy	+3,000	New	+$110K	0.03%	128

Other funds holding LKFT

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Barometer Capital Management's LKFT Position: Q1 2026 in Review

Barometer Capital Management increased its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 2.7% in Q1 2026, buying an estimated $33.1K and bringing the position to 38,100 shares worth $1.14M. The position accounts for 0.39% of the portfolio, ranked #61.

Barometer Capital Management first reported a position in LKFT in Q4 2023 and has held it in 10 quarters since. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2026.

Barometer Capital Management held 38,100 shares of Lakefront Biotherapeutics American Depositary Shares worth $1.14M as of Q1 2026.
Barometer Capital Management bought 1,000 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2026, an estimated $33.1K.
Lakefront Biotherapeutics American Depositary Shares made up 0.39% of Barometer Capital Management's portfolio in Q1 2026, its #61 holding.
Barometer Capital Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2023 and has held it in 10 quarters since.
90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2026.

Based on Barometer Capital Management's 13F filing for Q1 2026, filed 12 May 2026.